By focusing on metabolic health, strength training, gut balance, and hormone optimization , you can transition off Semaglutide or Tirzepatide without regaining weight
Women over 50 are among the most common GHK-Cu users, as natural levels of the peptide decline with age
GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes when other medications havent sufficiently managed blood sugar levels
Understanding recommended practices ensures optimal benefit whilst minimising unnecessary risks
Any mention of diseases on this site reflects how peptides are discussed in published research not intended use or medical claims
The SURMOUNT trials showed tirzepatide producing average weight loss of 20 to 22.5 percent at the highest dose over 72 weeks, compared to semaglutide 14.9 percent in STEP 1